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Introduction: Mobile phone text messaging is
emerging as an important tool in the care of people
living with HIV; however, reports diverge on its efficacy
in improving adherence to antiretroviral therapy (ART),
and little is known about which patient groups may
benefit most from phone-based adherence
interventions. We will conduct an individual patient
data meta-analysis to investigate the overall and
subgroup effects of text messaging in three recently
published text-messaging randomised controlled trials.
Methods and analysis: Data from two Kenyan and
one Cameroonian trial will be verified, reformatted and
merged. We will determine pooled effect sizes for text
messaging versus standard care for improving
adherence to ART using individual patient random-
effects meta-analysis. We will test for the interaction
effects of age, gender, level of education and duration
on ART. Sensitivity analyses will be conducted with
regard to thresholds for adherence, methods of
handling missing data and fixed-effects meta-analysis.
Only anonymised data will be collected from the
individual studies.
Ethics and dissemination: Ethical approval was
obtained for the individual studies. The results of this
paper will be disseminated as peer-reviewed
publications, at conferences and as part of a doctoral
thesis. This individual patient data meta-analysis may
provide important insights into the effects of text
messaging on ART adherence in different
subpopulations, with important implications for
programme implementation involving such
interventions and future research.
INTRODUCTION
More than 30 million people are living with
HIV worldwide.1 Over the past few years,
considerable progress has been made in the
treatment of HIV infection. Key among the
developments to control HIV is the advent of
antiretroviral therapy (ART). ART has been
shown to slow down disease progression,
prevent transmission and boost immunity;
however, its success depends on patients
achieving high levels of medication adher-
ence.2 Even though some evidence suggests
that patients with lower levels of adherence
can still achieve viral suppression,3 4 optimal
adherence is desirable since it is correlated
with improved clinical, immunological and
virological outcomes.2 5 6 On the other
hand, poor adherence can lead to progres-
sion to AIDS, the development of resistant
strains, increased transmissibility, more hospi-
talisations and longer stays.2 7 ART adher-
ence can be influenced by a number of
factors broadly categorised into patient-
related factors, medication characteristics,
ARTICLE SUMMARY
Article focus
▪ To outline the analytic plan for a collaborative
individual patient data meta-analysis of rando-
mised trials of text messaging to improve adher-
ence to antiretroviral therapy.
Key message
▪ Individual patient data meta-analysis can provide
insight into the patient groups most likely to
benefit from text messaging and the most effect-
ive kinds of messages.
Strengths and limitations of this study
▪ Robust analytical methods that take into account
within-study and between-study differences.
▪ No systematic search for other studies will be
carried out.
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health system characteristics and disease characteris-
tics.8–13 More specifically, females, people aged above
50 years and the more educated are more likely to be
adherent to ART.9 14 Adherence to ART may wane over
time.15 16
There is an emerging evidence that mobile phones
can play an important role in healthcare delivery, espe-
cially in resource-limited settings.17 The appeal of using
phones to promote adherence has grown as phone own-
ership rates continue to rise in sub-Saharan Africa and
elsewhere.18 Short message service (SMS) is a particu-
larly useful application that can be used to collect or
share information and to enhance communication
between health personnel and patients in a low-cost
manner.19 With regard to patient management, mobile
phone text messages have been demonstrated to induce
positive behaviour changes in domains such as smoking
cessation, physical activity and self management of high
blood pressure, diabetes and asthma.20 Other studies
report high levels of satisfaction among participants.21 22
In light of these, one can expect SMS texting to serve as
reminders to take medication, provide greater connect-
edness with a provider or provide encouragement to
remain adherent to ART.
A recent Cochrane systematic review synthesising data
from two trials conducted in Kenya showed that text
messaging is efficacious in improving adherence.22–24
A third trial conducted in Cameroon reported no
improvements in adherence.25 Yet, to the best of our
knowledge, there are no individual patient data
meta-analyses for this type of intervention. We will use
individual patient data to aggregate the findings from
these three randomised controlled trials.
The WHO recognises mobile health (mHealth) as a
potential resource for improving outcomes in low
resources settings.26 This paper will provide the best
available evidence for the use of text messages in
improving adherence to ART. It will also provide the
most accurate estimation of the extent to which, and the
subpopulations in whom, we can expect text messages to
improve adherence.
Objectives
Our primary objective is to determine the overall effect
of mobile phone text messages versus usual care for
improving adherence to ART using individual level data.
Our secondary objective is to investigate the effects of
mobile phone text messages in subgroups known to
have different adherence behaviours: gender, age, level
of education and duration on ART.
METHODS AND ANALYSIS
Overview of the trials and data sources
We have obtained individual patient data from three
trials: the CAMPS trial,25 the WelTel trial Kenya 122 and
one other in Kenya.23 The CAMPS trial (n=200) investi-
gated the use of weekly motivational text messages
versus usual care to improve adherence to ART in
Yaounde, Cameroon.25 The WelTel trial was a multisite
trial of weekly messages inquiring about participants’
status involving 538 participants in Kenya.22 Pop-Eleches
et al investigated short daily messages, long daily mes-
sages, short weekly messages and long weekly messages
compared to standard care in 431 participants in
Kenya.23 These studies were included based on the fol-
lowing criteria: they are all randomised controlled trials
of a text messaging intervention in people living with
HIV to improve their adherence to ART. The character-
istics of these studies are reported in detail in table 1. To
our knowledge, there are no other published rando-
maised controlled trials (RCTs) of text-messaging inter-
ventions designed to improve ART adherence in
resource-limited settings.
Data management
To promote collaboration with the authors of these
reports, we will adhere to the highest levels of confiden-
tiality and ensure professionalism by providing regular
updates on data handling and analysis.
We will collect baseline covariates, endpoint data and
coding information from each study. Data will be stored
on a controlled-access computer with backup and
treated confidentially. Data will be stored in its original
form, but copied for conversion into SPSS (IBM Corp.
Released 2011. IBM SPSS Statistics for Windows, V.20.0.
Armonyk, New York: IBM Corp). We will check for the
missing data and compare it with published trial reports.
Any discrepancies will be resolved by contacting the ori-
ginal authors. Data will also be checked for appropriate
ranges, for example, an age less than 10 years would be
implausible, since only adults were included in the
parent studies. Finally, all common variables will be allot-
ted new unified names and an identifier variable will be
added to participants from the same trial.
Data merging procedures
Only variables that are available in all three data sets will
be used. The categories reported in the individual
studies will be reformatted into new uniform categories
for the individual patient data meta-analysis. The final
data set will include the following baseline covariates:
age (years), gender (male/female), level of education
(none, primary, secondary or higher) and duration on
ART (months). The intervention variable will be text
messaging (short daily, long daily, short weekly or long
weekly modalities) versus no text messaging. The
primary outcome will be adherence > 95% with respect
to measures used in the three studies (by a visual ana-
logue scale at 6 months25; by medication event monitor-
ing system from week 12 through week 4823; and as a
percentage of pills taken at 6 and 12 months22).
Secondary outcomes include mortality, study withdrawal,
lost to follow-up and transfers. Table 2 describes the ori-
ginal format of the data and how they will be reformat-
ted for use in the individual patient data meta-analysis.
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Statistical methods
Analyses will include all study participants irrespective of
whether they received the allocated intervention
(intention-to-treat). Summary statistics will be presented
as mean (SD) or median (IQR) for continuous variables
and number (percent) for categorical variables. The
primary outcome will be adherence to ART. All three
studies have sufficient data to dichotomise adherence at
95%, defining adequate adherence (greater than 95%)
and poor adherence (95% or less). Effect sizes will be
computed for comparisons between the various text
messaging modalities versus no text messaging, and for
all forms of text messaging versus no text messaging. We
will report ORs and corresponding 95% CIs. The level
of statistical significance, α, will be set at 0.05. Forest
plots will be graphed for all pooled effects.
An individual patient random-effect meta-analysis will
be conducted to determine the overall effect of text
messaging on adherence, with ‘study’ as a random
effect, to model variation across studies and to account
for clustering within a study.27 This analysis will be
repeated for secondary outcomes. In an adjusted ana-
lysis, adherence to ART, our primary outcome and
dependent variable will be modelled as a function of the
intervention (text message/no text message) and base-
line characteristics (age, gender, duration on ART and
level of education) as fixed effects.
Model fit will be tested using maximum likelihood esti-
mations. Multicollinearity will be assessed using the vari-
ance inflation factor (VIF), with a VIF of 4 or more
considered as evidence of substantial multi-collinearity.
Data will be analysed using SPSS V.20.0 (SPSS, Inc, 2009,
Chicago, Illinois, USA). The data analysis plan is illu-
strated in figure 1.
Sensitivity analysis
We will also test the sensitivity of our results to a 90%
cut-off point for adherence, imputation of missing data
using multiple imputation28 and method of analysis
(fixed-effect vs random-effect meta-analysis). For the
individual patient fixed-effect meta-analysis, generalised
estimation equations (GEE) will be used to obtain the
Table 1 Characteristics of included studies
Lester et al Pop-Eleches et al Mbuagbaw et al
Design A multisite two-arm randomised
controlled trial
A single site five-arm
randomised controlled trial
A single site two-arm randomised
controlled trial
Inclusion criteria ≥18-years-old, initiating ART for
the first time, and able to access a
mobile phone on a near-daily
basis and communicate via SMS
≥18 age who had initiated
ART less than 3 months prior
to enrolment
≥21 years who owned mobile
phones, could read text messages





Gender, age, CD4 count, WHO
stage, clinic, viral load, literacy,
level of education, monthly





Age, gender, education, family
awareness of HIV status, presence
of OI, BMI, CDC stage, regimen,
duration on ART, CD4 count and
VAS adherence
Sample size 538 (intervention=273;
control=265)
431 (Short daily message=70;
Short weekly message=73;




Interventions Weekly text message inquiring
about status- Participants required





Varied weekly motivational text
message with response number
provided
Control Standard care Standard care Standard care
Primary
outcomes
Self reported adherence (in
preceding month), viral load
MEMS adherence VAS adherence, number of missed
doses (in preceding week), PRD
Secondary
outcomes
Attrition (loss to follow-up,
mortality, transfers, withdrawals)
Treatment interruptions Weight, BMI, opportunistic
infections, CD4 count, viral load,




12 months 48 weeks (12 months) 6 months





No improvements in adherence
ART, antiretroviral therapy; BMI, body mass index; CD4 count, CD4-positive-T-lymphocyte count; CDC, Centres for Disease Control and
Prevention; MEMS, Medication Event Monitoring System; OI, opportunistic infection; PRD, pharmacy refill data; QOL, quality of life; SMS,
short message service; VAS, visual analogue scale.
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average response over the population.29 An exchange-
able correlation structure will be assumed for this ana-
lysis—individuals within the same study are equally
correlated. We will also report estimates of effects based
on aggregate date from the individual studies.
Subgroup analysis
The findings from the included studies raise the possibil-
ity that text messaging may be more effective at improv-
ing adherence among individuals whose adherence is
likely to be lower in the absence of any intervention,
such as in males and individuals with higher levels of
education.22 25 For these subgroups, we will add the
interaction terms (subgroup-by-intervention interaction)
to the models. p Values for the interaction terms will be
reported.
Assessment of heterogeneity
For the pooled estimates of effect, heterogeneity
between studies will be measured using the τ2 statistic
(an estimate of the between-study variance in the
random-effects model). The χ2 test of homogeneity
(level of significance—α=0.10) and the I2 test (the per-
centage of the overall variation due to heterogeneity)
will be used in the fixed-effects models. The intraclass
correlation coefficients from the GEE will be reported.
Risk of bias
Risk of bias will be assessed using the Cochrane Risk of
Bias tool for randomised controlled trials.30
ETHICS AND DISSEMINATION
This individual patient data meta-analysis was exempt
from ethics approval by the Hamilton Integrated
Research Ethics Board, as it involves only anonymised
precollected data. Ethical clearance and informed
consent were obtained for each of the individual
studies.22 23 25 Only anonymised data will be collected
from the individual studies. We plan to disseminate our
results at international meetings and in peer-reviewed
journals. Our findings will also be publicly presented
and defended as part of a doctoral thesis.
DISCUSSION
We recognise the considerable resources and inter-
national cooperation required to perform a
meta-analysis based on individual patient data and will
build on already existing relationships31 to produce a
high quality meta-analysis.
The two Kenyan trials we included in this individual
patient data meta-analysis reported significant improve-
ments in adherence, while the third trial did not.
However, the populations and interventions in these
three trials, though similar in broad terms (adults living
with HIV receiving text messages to improve adherence),
are sufficiently different to warrant further investigation.
Other differences include the settings, interventions,
measures of adherence and duration of the trials.
The CAMPS trial used a variety of motivational text
messages developed based on the health belief theory of
Table 2 Data merging procedures
Variable Lester et al Pop-Eleches et al Mbuagbaw et al IPD* Meta-analysis
Age Years Years Years Years
Gender Male/female Male/female Male/female Male/female
Level of
education
No formal education None None None
Lower primary
Upper primary










Months Months Months Months
Intervention SMS short daily SMS short daily
SMS short weekly SMS short weekly SMS short weekly
SMS long daily SMS long daily
SMS long weekly SMS Long weekly SMS long weekly
Control No SMS No SMS No SMS No SMS
Adherence Yes (>95 at 6 &
12 months)




Yes (as reported in
studies)
Final outcome Lost to follow-up Lost to follow-up Lost to follow-up Lost to follow-up
Death Death Death Death
Withdrew Withdrew Withdrew Withdrew
Transferred out Transferred out Transferred out Transferred out
*Individual patient data.
SMS, short message service.
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behaviour change.25 Responses to these messages were
optional. The WelTel trial used a simple “How are you?”
to which participants were required to respond within
24 h.22 Pop-Eleches et al used messages designed to
address forgetfulness (short message) and lack of social
support (long message).23 Participants in this trial were
given Nokia mobile phones. All other studies ran for
12 months except the CAMPS trial which ended at
6 months. These differences may have consequences on
the effects of the interventions depending on partici-
pant preference for a specific kind of message and the
length of time required to measure a significant effect.
Some limitations worth noting include the differences
between the studies which limit the generalisability of
the findings, notably the different interventions and
measures of adherence. However, the availability of high-
quality data from three well-conducted studies and our
use of multilevel models to account for between-study
differences will provide reliable estimates of the effects
of text messaging on adherence to ART. Moreover, we
did not conduct any systematic search for other relevant
trials. Only these three trials were invited to participate
in the review.
Individual patient data meta-analysis holds several
advantages over aggregate meta-analysis including the
possibility of checking, exploring and reanalysing the
data in a consistent way. We can also perform more
complex analysis with regard to the associations between
interventions and patient characteristics. On the other
hand, individual patient data meta-analysis cannot deal
with bias originating from study design and conduct.32 It
may also be subject to publication bias.33
By identifying the subpopulations in which the inter-
vention is likely to be most beneficial, this paper will
address important clinical and operational questions
regarding the use of text messaging to improve adher-
ence to ART. Even though current guidelines encourage
the use of text messaging,34 additional knowledge can
Figure 1 Analysis plan for individual patient data.
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be gained from pooling and comparing data from indi-
vidual studies. Text messaging and other phone-based
interventions are unlikely to resolve adherence problems
for all patients. This paper will provide valuable guid-
ance on patient groups that may be targeted to receive
such interventions, thereby increasing cost-effectiveness
and freeing up resources to target other patients with
more intensive adherence interventions.
This paper will highlight the key characteristics that
are associated with a better response to text messaging
for the improvement of adherence to ART. Our findings
will inform future research and implementation
programmes.
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